EUVIMEDEUVIMED entdecken
Open Access

From splice defect to therapeutic opportunity: Insights from PRPF31

Frauke Coppieters

Molecular Therapy · 2026-10 · 34 (10) · 5624-5626

DOI: 10.1016/j.ymthe.2026.08.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Frauke Coppieters. Beteiligte Einrichtung: Department of Biomolecular Medicine, Department of Pharmaceutics, Center for Medical Genetics Ghent, Ghent University, Ghent, Belgium. Electronic add…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Foundation Fighting Blindness Inc, Ghent University, Research Foundation Flanders.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Biomolecular Medicine, Department of Pharmaceutics, Center for Medical Genetics Ghent, Ghent University, Ghent, Belgium. Electronic address: frauke.coppieters@ugent.be.

Förderung

  • Foundation Fighting Blindness Inc
  • Ghent University
  • Research Foundation Flanders

Zitieren

APA

Coppieters, F. (2026). From splice defect to therapeutic opportunity: Insights from PRPF31. Molecular Therapy, 34(10), 5624-5626. https://doi.org/10.1016/j.ymthe.2026.08.031

Vancouver

Coppieters F. From splice defect to therapeutic opportunity: Insights from PRPF31. Molecular Therapy. 2026;34(10):5624-5626. doi:10.1016/j.ymthe.2026.08.031

BibTeX
@article{Coppieters2026,
  author = {Coppieters, Frauke},
  title = {From splice defect to therapeutic opportunity: Insights from PRPF31},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {10},
  pages = {5624--5626},
  doi = {10.1016/j.ymthe.2026.08.031}
}
Kostenlos starten →